Unibest

Pharmaceutical intermediates

Lesinurad Intermediates

3 pharmaceutical intermediates for Lesinurad.

提交项目All intermediates

About Lesinurad

Originator
Astrazeneca
Approved Date
12/22/2015
DS/DP
08/25/2025

Available intermediates

3 intermediates currently listed for Lesinurad. Request specifications, documentation or a quotation for any item below.

Lesinurad intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Methyl 2-(5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate878671-99-9//
4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione1533519-84-4//
4-cyclopropylnaphthalen-1-aMine hydrochloride1533519-92-4//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Lesinurad?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →